Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-18

Clinical Trial Update: Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H. Pylori Eradication [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing Banxiaxiexin Decoction in combination with Vonoprazan-Amoxicillin dual therapy for Helicobacter pylori eradication has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)
  • Banxiaxiexin Decoction
  • Vonoprazan (vonoprazan)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Helicobacter Pylori Infection | Phase 3 | Status: COMPLETED